Abstract:Xanthine oxidase (XO), which plays a key role in purine metabolism, is an important target enzyme for the prevention and treatment of hyperuricemia. Inhibitory activity against XO is a common criterion for the screening of compounds with potential anti-hyperuricemic activity. In this study, 22 XO inhibitors were used to construct a 3D-QSAR pharmacophore model. Subsequently, molecular docking and in vitro activity evaluations were used to identify strong XO inhibitors from a list of 2000 natural compounds. The interaction mechanisms of these compounds with XO were analyzed based on inhibition kinetics and multi-spectral analyses. The pharmacophore model was composed of three hydrogen bond receptors and a hydrophobic center. The screened compounds - Diosmetin, Fisetin, and Genistein - all showed good XO inhibitory activity, with IC50 values of 1.86 ± 0.11 μM, 5.83 ± 0.08 μM, and 7.56 ± 0.10 μM, respectively. Kinetic analysis, fluorescence quenching assays, and molecular docking experiments showed that Diosmetin, Fisetin, and Genistein docked near the same active site of XO, mainly affecting the microenvironment of tryptophan residues. These molecules showed static binding to XO via hydrogen bonds, hydrophobic interactions, and van der Waals forces. Diosmetin and Genistein were competitive inhibitors, whereas Fisetin was a mixed inhibitor. Infrared spectroscopy showed that Diosmetin, Fisetin, and Genistein increased the α-helix content of XO from 7.4 % to 16.6 %, 21.4 %, and 11.2 %, respectively, thereby enhancing its stability. In summary, the pharmacophore model constructed in this study was accurate. The flavonoids Diosmetin, Fisetin, and Genistein effectively inhibited the activity of XO, and the amino acid residues LEU257, ILE353, and VAL259 played a key role in the interaction between the flavonoids and XO. These findings are of great significance for the screening and development of new XO inhibitors.

Systematic investigation of the amino acid profiles that are correlated with xanthine oxidase inhibitory activity: Effects, mechanism and applications in protein source screening

Xanthine Oxidase Inhibitory Peptides from Larimichthys polyactis: Characterization and In Vitro/In Silico Evidence

Exploration, Sequence Optimization and Mechanism Analysis of Novel Xanthine Oxidase Inhibitory Peptide from Ostrea Rivularis Gould.

Antihyperuricemic Activity and Inhibition Mechanism of Xanthine Oxidase Inhibitory Peptides Derived from Whey Protein by Virtual Screening.

Purification and Identification of Xanthine Oxidase Inhibitory Peptides from Enzymatic Hydrolysate of Α-Lactalbumin and Bovine Colostrum Casein.

Novel hemoglobin-derived xanthine oxidase inhibitory peptides: Enzymatic preparation and inhibition mechanisms

Screening of Xanthine Oxidase Inhibitor from Selected Edible Plants and Hypouricemic Effect of Rhizoma Alpiniae Officinarum Extract on Hyperuricemic Rats

Various machine learning approaches coupled with molecule simulation in the screening of natural compounds with xanthine oxidase inhibitory activity

Using deep learning and molecular dynamics simulations to unravel the regulation mechanism of peptides as noncompetitive inhibitor of xanthine oxidase

Novel Xanthine Oxidase Inhibitory Peptides Derived from Whey Protein: Identification, in Vitro Inhibition Mechanism and in Vivo Activity Validation

<p>Novel potential XOD inhibitory peptides derived from Trachinotus ovatus: Isolation, identification and structure-function analysis</p>

In Vitro and in Silico Xanthine Oxidase Inhibitory Activity of Selected Phytochemicals Widely Present in Various Edible Plants.

Xanthine oxidase inhibitors: Virtual screening and mechanism of inhibition studies

Separation, Identification and Docking Analysis of Xanthine Oxidase Inhibitory Peptides from Pacific Cod Bone-Flesh Mixture

Identification of Natural Xanthine Oxidase Inhibitors: Virtual Screening, Anti-Xanthine Oxidase Activity, and Interaction Mechanism.

Mining Xanthine Oxidase Inhibitors from an Edible Seaweed Pterocladiella capillacea by Using In Vitro Bioassays, Affinity Ultrafiltration LC-MS/MS, Metabolomics Tools, and In Silico Prediction

Exploring the potential of novel xanthine oxidase inhibitory peptide (ACECD) derived from Skipjack tuna hydrolysates using affinity-ultrafiltration coupled with HPLC-MALDI-TOF/TOF-MS.

Establishment and Optimization of an In-vitro Method for Screening Anti-hyperuricemic Peptides

A Strategy for Inhibitors Screening of Xanthine Oxidase Based on Colorimetric Sensor Combined with Affinity Chromatography Technology

Natural Xanthine Oxidase Inhibitor 5-O-Caffeoylshikimic Acid Ameliorates Kidney Injury Caused by Hyperuricemia in Mice

Spectroscopic Relationship between XOD and TAOZHI Total Polyphenols Based on Chemometrics and Molecular Docking Techniques